
Provider review
NP2GO review
By Derek Olsson ·
Publishes its full per-dose pricing matrix openly — rare in this category
It publishes the whole per-dose matrix, which almost nobody here does, and runs two models: pay-as-you-go with a $99 visit fee quarterly, or a flat $399 membership that becomes the cheaper option at high tirzepatide doses. Not LegitScript-certified.
Straight talk: how we earn — some, not all, of these are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.
On this page
The verdict
NP2GO is a nurse-practitioner-led hybrid telehealth and clinic operation, founded in 2019 and affiliated with the Obesity Medicine Association, covering 39 states plus DC. It publishes its full compounded semaglutide and tirzepatide pricing matrix openly by dose, with two paths: Pay As You Go (entry semaglutide $150/month at 0.25mg, plus a $99 visit fee every 3 months) or a flat Month-to-Month Membership that becomes the better deal at higher tirzepatide doses, where Pay As You Go runs $475-$600/month against a $399/month membership rate. It is not LegitScript-certified, and its compounding pharmacy partner is not named on the site.
NP2GO isn't on any of our comparisons yet. The providers we compare in this category are on our semaglutide provider ranking. Nothing on this page is a performance claim — see how semaglutide works for what the treatment does and does not do.
Alternatives to NP2GO
Other providers we work with. Compare prices before you sign up anywhere.

welludr.Partner
No single ongoing calendar-month cost can be established from those headlines
WillowPartner
Semaglutide starts at $299/month and tirzepatide $399/month

CollectivePartner
$59/mo + $199/yr
Who it is for, and who it is not
A good fit if
- You want to see the exact price at every dose tier before committing, not just an entry figure
- You're at a high tirzepatide dose, where the membership model saves real money over Pay As You Go
- You value a nurse-practitioner-led model affiliated with the Obesity Medicine Association
Look elsewhere if
- You're in one of the 11 states NP2GO doesn't serve (AL, GA, IN, LA, MO, MS, NC, OH, SC, TN, WI)
- You want LegitScript certification before enrolling
- You want the compounding pharmacy named
What it actually costs
What they advertise
Compounded semaglutide "$150/mo" (0.25mg, Pay As You Go); high-dose tirzepatide "$475-$600/mo" Pay As You Go or "$399/mo" on the Membership plan, per its own site.
What you actually pay, month to month
The $150/mo entry figure is real for the starting dose; the full matrix published on-site shows every tier, and the membership plan becomes cheaper than Pay As You Go at high tirzepatide doses.
Money you will meet later
- A $99 visit fee applies every 3 months on the Pay As You Go plan
Prices come from NP2GO's own website and can change without notice — confirm before you buy. Work out what a vial actually gives you with our peptide dose calculator.
What is included
Compare the total cost, including fees and any minimum commitment. Here is what NP2GO bundles in, and what it does not.
Clinician consult
A visit fee
($99 every 3 months on Pay As You Go) is billed separately from medication, per the homepage.
Bloodwork / labs
Not published
Follow-ups and dose changes
No cadence published beyond the visit-fee cycle
Human support
Nurse-practitioner-led care, per the homepage
Injection supplies
Not itemized
Shipping
No terms published
Pharmacy, labs and oversight
The pharmacy
Not named.
Oversight
No cadence published beyond the visit-fee cycle.
Compounded peptides are not FDA-approved products, and a 503A pharmacy compounds for a named patient while a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Our guide to verifying a certificate of analysis covers what to ask for.
Where you can get it
39 states plus DC; not available in AL, GA, IN, LA, MO, MS, NC, OH, SC, TN, WI, per the homepage.
The honest cons
The part they would rather you skipped
The pricing matrix itself is unusually transparent, but neither a LegitScript certification nor a named compounding pharmacy backs up the medication those published prices actually buy.
- Not LegitScript-certified
- Compounding pharmacy not named
- Not available in 11 states
- High-dose tirzepatide on Pay As You Go ($475-$600/mo) is expensive unless you switch to the membership plan
Weigh these trade-offs against the costs, care and terms above. For questions to ask before enrolling, see our vendor red-flags guide.
Similar providers
- Nu Image MedicalA selected recurring total is not establishedRead review →

- NowPatientPrice not publishedRead review →

- NuBloomThe $149/$279 figures are real starting…Read review →

- NovoCare PharmacyWegovy prices depend on form, dose and eligibilityRead review →

- NucificCurrent term and maintenance quotes need confirmationRead review →

- NoviThe $174/mo figure is genuinely…Read review →

Side by side: our semaglutide provider ranking · Every provider we review →
Read this before you buy
A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.
Provider offers and terms are based on NP2GO's public information. Other sources, where used, are identified in this review. Prices and terms change without notice — confirm on NP2GO's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.